Biotech VC Funds

Ada Ventures is a London-based venture capital firm focused on supporting early-stage startups with a particular emphasis on diversity and inclusion. Founded by Check Warner and Matt Penneycard, Ada Ventures aims to back founders who are often overlooked and underfunded, targeting sectors like climate equity, economic empowerment, and healthy aging​. The firm typically makes initial investments of around £500,000 and has developed innovative deal-sourcing methods, including a scout network and angel investment programs to reach underrepresented communities. This approach has led to successful investments in companies such as Huboo, Organize, and MOONHUB. Ada Ventures' portfolio from its first fund has raised an aggregate of £100 million in additional funding from prominent firms like GV and Index Ventures. Ada Ventures recently launched its second fund, raising £41 million in the first close, demonstrating strong support from the investor community and its commitment to creating a more inclusive venture capital landscape.

Adams Street Partners, founded in 1972, is a global leader in private markets investment management, with over $60 billion in assets under management. Based in Chicago, the firm operates across North America, Europe, and Asia-Pacific, investing through strategies that include primary, secondary, growth equity, credit, and co-investments. Adams Street Partners is particularly known for its expertise in venture capital, private equity, and fund of funds strategies. The firm has a long history of venture capital investments, having been active in the space since the 1970s. Their venture capital portfolio focuses on innovative, high-growth sectors such as healthcare, AI, enterprise software, and fintech. Adams Street also manages dedicated funds for early-stage companies and emerging managers. The firm’s strategic investment approach is designed to generate strong, risk-adjusted returns over time by supporting companies through market cycles and downturns. Adams Street Partners continues to build on its reputation by backing both new startups and established companies, making significant contributions to technological and industrial advancements. With a focus on long-term growth and innovation, the firm remains a prominent player in global private equity and venture capital.

Adara Ventures, founded in 2005 and headquartered in Madrid, Spain, specializes in early-stage investments in deep tech companies, focusing on sectors like cybersecurity, data and applications, infrastructure, DevOps, components, and digital health. Managing around €200 million in assets, Adara has invested in 85 companies. Their portfolio includes notable companies such as Seedtag, Scalefast, and AlienVault. Seedtag, a leader in Contextual AI for the AdTech industry, is one of their standout investments. Adara led Seedtag's initial €1.5 million round and has supported the company through its significant growth and recent €250 million funding round led by Advent International. Adara has seen several successful exits, including AT&T Cybersecurity and PlayGiga, showcasing their ability to identify and nurture high-potential startups. They typically invest in seed, Series A, and Series B rounds, with check sizes ranging from $500,000 to $3 million. The Adara team includes experienced professionals like Managing Partners Alberto Gómez and Nicolas Goulet, and Partner Alberto Echeverri, who bring extensive expertise to support their portfolio companies' growth and success. Adara Ventures continues to play a significant role in the European venture capital landscape, particularly in Spain and Western Europe.

AdBio Partners, previously known as Advent France Biotechnology, is a Paris-based venture capital firm specializing in early-stage investments within the life sciences sector. Established in 2016, AdBio Partners focuses on identifying and nurturing promising startups across Europe, particularly in France, Belgium, Spain, and Ireland. Their investment strategy is centered on therapeutics, supporting innovative biotech projects with high potential to address unmet medical needs. The firm is deeply integrated into the European life sciences ecosystem, collaborating closely with research institutions and technology transfer offices to transform groundbreaking scientific discoveries into viable businesses. AdBio Partners also plays an active role in the development of its portfolio companies, often co-founding and providing hands-on operational support to ensure their growth and success. Led by an experienced team of professionals with extensive backgrounds in science, medicine, and entrepreneurship, AdBio Partners has successfully attracted international VC syndicates, further strengthening its portfolio. Some notable companies backed by AdBio include DiogenX and ARTHEx Biotech.

Addition is a venture capital firm founded in 2019 by Lee Fixel, previously a key investor at Tiger Global. Based in New York, Addition focuses on early and growth-stage technology companies, emphasizing sectors like e-commerce, SaaS, and fintech. Their notable investments include high-profile companies such as Allbirds, Freshworks, Chainalysis, Delhivery, dLocal, Hugging Face, Snyk, and Warby Parker. Geographically, Addition primarily targets investments in the United States, though they have a broad international scope due to their interest in global tech innovators. Their investment strategy involves a significant allocation towards both early-stage and growth-stage companies, with about one-third of their capital dedicated to early-stage ventures and the rest to more mature businesses. This allows them to support startups through various phases of their development. Addition's team is led by Fixel, who is the sole partner and decision-maker, ensuring a streamlined and decisive investment process. The firm is known for its strategic and empathetic approach, focusing on building long-term partnerships with entrepreneurs and fostering growth in their portfolio companies through active engagement and support. For startups seeking investment, Addition values clear demonstrations of potential for market leadership and significant growth. They prefer companies with a proven track record of profitability and sustainable competitive advantages. The firm's commitment to preserving legacy and company culture makes them a preferred partner for founders looking for a strategic, long-term investor.

Advantage Capital is a prominent impact investment firm founded in 1992, dedicated to providing financing to businesses and communities often overlooked by traditional capital sources. The firm has invested over $4.2 billion in more than 800 companies across various industries, including technology, renewable energy, and affordable housing. Some of their notable investments include NevadaNanotech Systems, which develops portable devices for real-time chemical analysis, and North End Teleservices, a contact center services provider in North Omaha aimed at creating local jobs and economic growth. TurboSquid, a global online marketplace for digital 3D models, is another key investment that highlights Advantage Capital's support for tech innovation and economic development in New Orleans​​. Advantage Capital emphasizes impact investing, focusing on outcomes such as job creation, community revitalization, and environmental sustainability. In 2022, the firm invested $85 million in affordable housing and raised over $635 million for solar energy projects, underscoring their commitment to driving meaningful change in underserved areas.

Advent Life Sciences is a leading transatlantic venture capital firm that focuses on investing in early and mid-stage life sciences companies. The firm emphasizes innovation in areas such as new drug discovery, medical technology, enabling technologies, and vaccines. Advent Life Sciences takes a hands-on approach, working closely with management teams to bring their visions to life, aiming for superior financial returns by bringing innovative solutions to patients. Advent Life Sciences has a strong portfolio of companies that have brought significant advancements in healthcare. Notable investments include AviadoBio, which focuses on gene therapy for neurodegenerative disorders, and Amphista Therapeutics, which develops protein degradation technologies for targeted cancer therapies. The firm also backs companies like Cellnovo, which created a micro insulin pump with connectivity, and Centessa Pharmaceuticals, a novel asset-centric pharmaceutical company. The firm is known for its experienced team of professionals, combining deep technical, commercial, and financial expertise. Key team members include Don Drakeman, Majid Kazmi, and Katrine Bosley, who bring substantial industry knowledge and strategic guidance to their portfolio companies. Advent Life Sciences is committed to supporting the growth of life sciences innovations, helping companies navigate the complex journey from scientific discovery to market-ready products.

Aera VC is a venture capital firm focused on investing in climate tech and frontier technologies that aim to advance humanity and create a sustainable future. Founded in 2016 by Derek Handley and Nick Winstone, Aera VC operates from New York, Singapore, and New Zealand. The firm invests globally, targeting early-stage companies that drive transformational change across various industries. Notable investments include Solugen, which transforms chemicals using plant-based processes, and Twelve, a company that recycles CO₂ into cost-competitive chemicals and fuels. Other significant investments are Shiok Meats, a Singapore-based company developing cell-based seafood, and Carbon Chain, which offers solutions to reduce greenhouse gas emissions in supply chains. Aera VC also supports startups like AstroForge, focused on space technology, and Paloma Health, an online medical practice specializing in hypothyroidism. Aera VC recently raised $42 million in the first close of its new climate-focused fund, which will be used to back up to 30 new seed investments over the next two years. The firm aims to support breakthrough technologies that can significantly reduce the world's carbon footprint and advance sustainable practices across various sectors.

Aescuvest is a prominent pan-European venture capital firm that specializes in health technology. Headquartered in Frankfurt, Germany, Aescuvest collaborates with EIT Health, giving it exclusive access to some of the most promising healthtech startups across Europe. The firm focuses on early to late-stage ventures, investing in areas such as remote monitoring, diagnostics, personalized medicine, and AI in healthcare. Notable investments include startups like Neteera and Caresyntax, showcasing their commitment to advancing healthcare technology. Aescuvest's strategy emphasizes a rigorous selection process and thorough due diligence to ensure exponential growth potential for their investments. They prefer to lead funding rounds and remain actively involved in the growth of their portfolio companies. Aescuvest targets investments primarily within Europe and Israel, fostering a network of healthcare technology-driven investors, including business angels and corporate investors. The fund's typical investment size averages around $2.85 million per round. For startups seeking investment, Aescuvest values innovation that promises substantial improvements in patient outcomes and healthcare delivery. Their approach to building an investment funnel involves leveraging partnerships and a deep understanding of the healthtech sector to identify high-impact opportunities. Key team members include experts deeply rooted in the healthcare industry, such as Helmut Nanz, whose experience and strategic insight drive Aescuvest's mission to transform healthcare through technology.

AF Ventures, formerly known as AccelFoods, is a venture capital firm based in New York that invests in high-growth consumer product companies. Established in 2014, the firm focuses on sectors such as food and beverage, health and wellness, personal and household care, beauty, and pet products. AF Ventures typically invests in companies with $10-30M+ in top-line revenue, aiming to support the creation of enduring brands. Notable investments by AF Ventures include Harmless Harvest, ByHeart, Proud Source Water, Koia, Siete Foods, and Hello Bello. The firm provides financial capital along with strategic support, leveraging a network of industry experts to help portfolio companies achieve significant growth and innovation. AF Ventures is committed to driving consumer brand innovation on retail shelves and online platforms. They manage over 35 portfolio brands and continue to identify and support companies that offer unique and disruptive products in their respective markets.

Afore Capital is a San Francisco-based venture capital firm specializing in pre-seed stage investments. Founded in 2016, Afore Capital manages a $300 million fund and typically invests $500,000 to $2 million in early-stage companies that are pre-traction and pre-revenue. The firm focuses on identifying high-potential startups and helping them rapidly scale towards Series A funding rounds. Afore Capital’s diverse portfolio includes companies across sectors such as SaaS, fintech, healthcare, consumer, and enterprise technology. Notable investments include Neo Financial, a digital bank; BetterUp, a platform for professional coaching; and Curefit, a provider of digital and offline fitness services. The firm has a strong track record, with several successful exits and notable co-investments alongside top venture funds like Andreessen Horowitz and Accel​.

AgFunder is a venture capital firm founded in 2013, with headquarters in Silicon Valley. The firm focuses on investing in transformative technologies within the food and agriculture sectors. Their investment strategy emphasizes bold and impactful innovations that address critical challenges such as climate change, population growth, and sustainability in food production. Notable investments in AgFunder's portfolio include companies like DeHaat, which is a farmers' business network for smallholder farmers, and MycoWorks, known for producing leather alternatives from mycelium. Other significant investments include Verdant Robotics, a robotics-as-a-service company specializing in agricultural spraying, and Wefarm, a peer-to-peer network for farmers in Eastern Africa. AgFunder's thematic investment approach targets high-impact areas such as indoor farming, precision agriculture, and alternative proteins. They leverage their extensive network of founders, operators, and investors to support their portfolio companies in scaling globally. The firm has raised multiple funds and invested in over 85 companies, making them one of the most active foodtech and agtech VCs worldwide. Their leadership team combines technological expertise with market knowledge, enabling them to support startups effectively from early stages through to larger growth phases. AgFunder’s mission is to drive radical transformation in the food and agriculture systems through advanced technologies​.

Agronomics is a London-listed investment firm leading the charge in cellular agriculture, a field focused on producing agricultural products directly from cell cultures rather than through traditional farming. This approach holds promise in addressing critical issues like climate change, deforestation, and food insecurity. Agronomics invests in ventures aiming to disrupt animal husbandry and conventional food production, focusing on meat, dairy, leather, and other products derived through cutting-edge biotechnology, precision fermentation, and tissue engineering. Their portfolio includes over 20 companies, such as Meatable, a cultivated meat firm specializing in pork and beef, and BlueNalu, which is developing cell-based seafood products. These startups are pioneering solutions to replace conventional protein sources with more sustainable alternatives, reducing environmental impact and improving food security. Agronomics typically targets early-stage investments, leveraging its expertise to support companies through technological and regulatory challenges. The firm invests globally, with a particular focus on the rapidly growing precision fermentation and cellular agriculture sectors. Their goal is to not only provide capital but also help drive regulatory approvals and scalability for sustainable food production. Led by co-founders Jim Mellon and Denham Eke, Agronomics offers a unique blend of financial and scientific insight. Their active approach includes deep involvement in company growth strategies, particularly around impact and sustainability metrics. This positions Agronomics as a leader in shaping the future of food technology.

Ahren Innovation Capital is a deep tech and science-focused investment firm, aiming to support transformational companies at the intersection of cutting-edge science and technology. With over $400 million in their latest fund, Ahren targets companies working in domains such as AI, genetics, robotics, and sustainable energy. They take an active role in nurturing early-stage to pre-IPO companies, focusing on ventures that have the potential to create new markets or disrupt existing ones. Ahren’s portfolio includes pioneering companies like Graphcore (AI hardware), Edifice Health (inflammatory disease diagnostics), and Meatable (cultivated meat). Their science partners include Nobel laureates and renowned scientists like Sir Gregory Winter and Lord Martin Rees, who bring deep expertise to the diligence process and ongoing business support. The firm has a strong network of strategic LPs, giving their portfolio access to key industry partners and customers. Led by Alice Newcombe-Ellis, Ahren's model blends visionary investment with commercial acumen, helping companies scale while maintaining a commitment to groundbreaking innovation. They prioritize building lasting relationships with founders, positioning themselves as trusted partners who contribute both capital and deep technical knowledge​.

AI Seed is a London-based venture capital firm that focuses on early-stage investments in artificial intelligence startups. Founded in 2017, it has built a reputation as one of the UK's leading AI funds, with a portfolio exceeding 40 companies. Notable investments include Odin Vision, Rahko, and Facesoft. AI Seed supports startups primarily in sectors such as healthcare, finance, and business software, aiming to invest in innovative AI applications with the potential for significant market disruption. The fund typically invests around £100,000 in each startup, seeking 5-10% equity and often leading the seed round. It also provides extensive mentorship and support, leveraging its network to help startups access AI talent, commercial partners, and growth opportunities. AI Seed’s leadership team, including Michael Axelgaard, Jacques de Cock, and Steve Weis, brings a wealth of experience from previous successful ventures, combining technical expertise with operational know-how. While primarily active in the UK, the fund maintains connections in Silicon Valley, offering startups valuable international exposure. AI Seed’s approach emphasizes hands-on involvement, from initial funding through to scaling, with a clear strategy to prepare startups for follow-on funding and growth. The fund’s emphasis on AI-specific solutions makes it a valuable partner for founders looking to innovate within this space.

African Infrastructure Investment Managers (AIIM) is a prominent private equity firm that focuses on investing in critical infrastructure projects across Sub-Saharan and North Africa. Established in 2000, AIIM is a wholly-owned subsidiary of Old Mutual Alternative Investments, one of Africa’s leading investment groups. The firm’s headquarters is in Cape Town, South Africa, with additional offices in Nigeria, Kenya, and Côte d'Ivoire, allowing it to have a deep understanding of the diverse African business environment. AIIM manages assets valued at approximately USD 2.8 billion and has a robust portfolio of over 74 infrastructure projects spanning various sectors, including energy, transport, telecommunications, and water. The firm’s investment philosophy is centered on long-term value creation, targeting projects that not only offer substantial financial returns but also contribute to the economic development and sustainability of the regions they serve. AIIM's track record includes managing several highly successful funds, such as the African Infrastructure Investment Fund (AIIF) series, which has been instrumental in financing large-scale infrastructure projects across the continent. These funds focus on sectors that are critical to Africa's growth, including renewable energy, where AIIM has made significant investments to help transition the continent to more sustainable energy sources. With a team of 44 investment professionals, AIIM brings extensive experience and sector-specific knowledge, ensuring that their investments are managed with the highest level of expertise. AIIM continues to play a vital role in driving Africa’s infrastructure development, helping to unlock economic potential and improve the quality of life for millions across the continent.

Air Liquide, a global leader in gases, technologies, and services for industry and healthcare, is deeply committed to advancing sustainability and innovation through its strategic plan, ADVANCE. This strategy, designed for 2025, integrates financial performance with sustainable development goals, focusing heavily on decarbonization and the growth of key future markets, such as hydrogen and electronics. The company plans to reduce its CO₂ emissions by one-third by 2035 and aims for carbon neutrality by 2050. To achieve these goals, Air Liquide is investing significantly, with approximately 50% of its industrial investments allocated to the energy transition, including hydrogen technologies. The company is also simplifying its organizational structure to enhance agility and performance, enabling quicker decision-making and better customer service. Air Liquide’s efforts in decarbonization are demonstrated by projects like the large-scale Cryocap™ CO₂ capture unit in Rotterdam and the development of a global hydrogen distribution network through partnerships like TEAL Mobility with TotalEnergies. With over 66,000 employees across 60 countries, Air Liquide continues to drive forward with its dual focus on growth and sustainability, positioning itself as a leader in the transition to a low-carbon economy​.

Air Street Capital is a leading venture capital firm focused on AI-first companies, headquartered in London. Founded by Nathan Benaich, the fund aims to back innovative startups leveraging artificial intelligence across various sectors, including life sciences, enterprise software, and consumer technology. The firm has made significant investments in notable companies such as Exscientia, a pharmaceutical company listed on NASDAQ; Graphcore, an AI semiconductors company acquired by SoftBank; and Intenseye, a workplace safety platform utilizing computer vision. Other prominent investments include Recursion, ZOE, and Stability AI. Air Street Capital's investment strategy involves early-stage funding, actively iterating on product and market strategies from day one. The fund's typical investment size ranges from seed to Series A rounds, ensuring substantial support for startups at their most critical stages of development. The firm emphasizes creating enduring companies with lasting market impact, guided by a rigorous, science-driven approach to investment. The team at Air Street Capital includes experts like Alex Chalmers and Paula Pastor, who bring extensive experience in legal, operations, and platform development. Their collective expertise and strategic insights help portfolio companies navigate complex challenges and scale effectively. With a robust portfolio and a clear focus on AI-driven innovation, Air Street Capital stands out as a pivotal player in the venture capital landscape, driving forward the capabilities and applications of artificial intelligence across industries​.

Airbridge Equity Partners is an Amsterdam-based venture capital firm founded in 2017, focusing on early-stage and growth-stage investments in technology-driven companies across Europe. The firm targets scalable ventures in both B2B and B2C sectors, particularly within the digital landscape. Airbridge is known for its flexible approach, offering equity investments, follow-on expansion capital, and venture debt, allowing them to support companies throughout their growth journey. In 2023, Airbridge closed its second fund, AEP-II, with a commitment of €63 million, marking a significant step in expanding its influence in the European tech ecosystem. The fund is distinguished by its inclusion of external Limited Partners (LPs) for the first time, some of whom are founders of companies that Airbridge previously backed. This reflects strong confidence in the firm’s strategic vision and investment expertise. Airbridge’s portfolio includes notable companies like Smartlook, Roam.ai, and Honey Sales. The firm's investment strategy is centered on building deep partnerships with ambitious management teams, leveraging their extensive sector knowledge to drive growth and innovation in the tech space.

Airbus Ventures, established in 2016 and headquartered in Menlo Park, California, is the venture capital arm of Airbus Group. The firm focuses on early to growth-stage investments in innovative startups that aim to address significant global challenges through advanced technologies. Their investment sectors include autonomous mobility, electrification, low-carbon economy, advanced materials, manufacturing systems, next-generation computing, sensing, and security. The portfolio of Airbus Ventures includes a wide range of companies that leverage cutting-edge technology. Notable investments include IonQ, a developer of quantum computing solutions; Astra, a provider of space mission launch solutions; and Humatics, which develops control systems for collaborative robots. Other significant investments are in companies like AEye, specializing in AI and cloud-enabled LiDAR sensors, and Tekion, an AI-driven dealership management system for auto dealers. Airbus Ventures has successfully nurtured numerous startups, with several achieving significant milestones such as public listings or acquisitions. For example, IonQ went public and is a leading player in the quantum computing space, while Astrocast and ispace are other prominent companies in their portfolio that have made substantial progress in their respective fields. The firm is managed by a team of experienced professionals, including Thomas d'Halluin, Claas Kohl, Lewis Pinault, and Mathieu Costes, who bring extensive expertise in venture capital and technology innovation.

AIX Ventures is a specialized venture capital firm dedicated to investing in early-stage AI startups. Founded by renowned AI practitioners such as Richard Socher, Chris Manning, and Pieter Abbeel, AIX Ventures is deeply embedded in the AI community. The firm’s focus is on partnering with companies where AI is a core component of the product, spanning sectors like natural language processing, robotics, healthcare, and more. AIX Ventures manages its investments through funds, including its recent $202 million Fund II, which underscores its commitment to driving the future of work through AI. The firm typically invests between $1 million and $5 million at the Pre-Seed to Series A stages and is known for leading funding rounds while collaborating with other top investors and angels. The firm's portfolio includes groundbreaking AI companies such as Hugging Face, Weights & Biases, You.com, and Perplexity. These companies are at the forefront of AI innovation, pushing the boundaries of what is possible in their respective fields. AIX Ventures is not just an investor but also a partner in company-building, offering strategic guidance, technical expertise, and a strong network to help founders navigate the complex challenges of scaling AI technologies. The firm’s goal is to be deeply involved with its portfolio companies from the early stages through to their long-term success.

Alante Capital is an early-stage venture capital firm focused on fostering innovation in the fashion, home, and outdoor industries by investing in climate tech, deep tech, AI, and enterprise software. Co-founded by Karla Mora and Leslie Harwell, Alante Capital aims to address climate change and build a circular economy through their investments. They primarily target companies that are modernizing and building resilience in consumer industries, with a particular emphasis on reducing carbon emissions and improving the sustainability of supply chains. Alante Capital’s portfolio includes investments in companies like Insempra, Mango Materials, and Novoloop, which are pioneering sustainable solutions across various sectors. Their investment strategy is comprehensive, with a focus on technologies that transform how products are designed, produced, and managed throughout their lifecycle. The firm typically invests in North America and Europe, with check sizes ranging from pre-seed to Series A. The team, based in Santa Barbara, CA, and New York, brings a wealth of experience in impact investing, sustainable finance, and economic development. Karla Mora's background includes working with early-stage companies in emerging markets, while Leslie Harwell has a strong foundation in sustainable finance and capital strategy.

AlbionVC, founded in 1996 and based in London, is a leading venture capital firm that focuses on early-stage investments in B2B software, healthcare, and deep tech companies primarily in the UK. The firm manages around £1 billion in venture funds and supports companies from seed to Series B stages. Notable investments in AlbionVC's portfolio include Quantexa, a data and analytics company specializing in contextual decision intelligence; Oviva, which provides app-guided programs for changing dietary and lifestyle habits; and Phrasee, a brand language optimization solution. The firm has also seen successful exits, such as Orchard Therapeutics, which focuses on gene therapies for life-threatening diseases, and Egress Software, a provider of data security solutions. AlbionVC is known for its hands-on approach, providing long-term capital and expertise to help visionary founders scale their businesses. The firm's investment strategy is characterized by its deep sector knowledge and a strong focus on innovation and growth.

BioCity is a leading life sciences incubator and early-stage investor, renowned for its focus on nurturing innovative ventures within the UK’s vibrant biotech ecosystem. With hubs across Nottingham, Alderley Park, and Scotland, BioCity supports a wide array of startups, especially those pioneering breakthroughs in biotechnology, medical devices, and drug discovery. The fund typically invests between £50,000 to £250,000, targeting companies at the seed stage, often co-investing alongside industry giants like AstraZeneca and prominent angel investors. Notable investments include Maxwellia, a pioneer in converting prescription drugs to over-the-counter solutions, and NanoSyrinx, which is developing precision therapeutics. BioCity's strategic approach is sector-agnostic within life sciences, providing not just capital but also high-end laboratory space, business support, and access to a network of industry experts. The team is led by seasoned professionals, including Dr. Imelda Juniarsih, known for her keen eye in identifying high-potential early-stage ventures. While their primary geographic focus is the UK, they are open to opportunities that align with their mission of advancing life sciences innovation. Startups seeking investment are encouraged to engage early, as BioCity values deep, collaborative relationships with its portfolio companies, often built through long-term incubation and mentorship.

Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a prominent real estate investment trust (REIT) specializing in collaborative life science campuses. Founded in 1994, Alexandria is a pioneering force in the life science real estate niche, owning, operating, and developing innovative campuses in major urban locations known for their scientific and technological advancements. The company's extensive portfolio spans key innovation clusters across North America, including Greater Boston, San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of March 31, 2024, Alexandria's total market capitalization is $34.4 billion, with an asset base of 74.1 million square feet, which includes operating properties, properties under construction, and planned development projects. Alexandria's success is built on its proven cluster model, which integrates essential components such as strategic location, cutting-edge innovation, top-tier talent, and substantial capital. This model has allowed the company to create and nurture thriving life science ecosystems that facilitate groundbreaking research and development in fields such as biotechnology, pharmaceuticals, and agtech. In addition to real estate, Alexandria operates several strategic verticals, including Alexandria Venture Investments, which invests in disruptive life science companies, and a strong focus on corporate responsibility, promoting sustainability and social impact initiatives. The company's mission-driven approach and operational excellence make it a trusted partner for nearly 800 tenants, driving stable and resilient cash flows through high-quality, long-term leases with diverse tenants.

Alix Ventures is a venture capital firm dedicated to supporting early-stage life science startups, particularly those driving advancements in human health through the innovative fusion of technology and biology, often referred to as "TechBio." Founded by a team of experienced life science entrepreneurs, Alix Ventures aims to partner with founders who possess unique insights and the ambition to tackle some of the most pressing challenges in healthcare. The firm focuses on companies that are engineering biology to create transformative solutions, with a portfolio that includes startups like Xilis, Elegen, and Endpoint Health. These companies are at the forefront of developing technologies that enable precision medicine, advanced DNA writing, and immunology. Alix Ventures operates primarily out of San Francisco and Boston, but they also have a presence in other U.S. cities. They are known for their strong support network, providing not just capital but also valuable connections to industry experts, follow-on VCs, and key opinion leaders in pharma and healthcare. The firm’s advisory board comprises PhD-level bioengineers and industry veterans, ensuring deep technical diligence across a broad spectrum of life science sub-domains. With a strong commitment to driving patient impact, Alix Ventures continues to support breakthrough innovations that push the boundaries of what's possible in life sciences.

AllegisCyber Capital, founded in 1996, is a venture capital firm exclusively focused on early-stage cybersecurity investments. The firm has offices in California, Maryland, and Utah, and specializes in seed and early-stage funding. Their investment strategy emphasizes innovative technologies in areas like big data analytics, IoT, and virtualization, aiming to secure the digital infrastructure crucial to various industries including banking, retail, healthcare, and government. AllegisCyber Capital's notable investments include Dragos, a leader in industrial cybersecurity; SafeGuard Cyber, which focuses on digital risk protection; and SkyHive, an AI-based labor market intelligence platform. They also support companies like HiddenLayer and Immuta, which are at the forefront of cybersecurity and data privacy solutions. Led by industry veterans such as Bob Ackerman, AllegisCyber leverages its deep domain expertise and market knowledge to provide strategic support to its portfolio companies, helping them navigate the complex cybersecurity landscape and achieve significant growth.

AI2 Incubator, founded by Paul Allen's Allen Institute for AI, is a Seattle-based incubator focused on launching groundbreaking AI startups. With a mission to support AI-driven innovation, AI2 Incubator provides pre-seed investments of up to $500,000, access to $1M in cloud computing credits, and AI product development resources. Startups in its portfolio span critical areas like foundation models, AI for social good, and domain-specific AI. Some of their notable alumni include companies like Lexion, WhyLabs, and WellSaid Labs, with the incubator's startups collectively raising over $220 million. AI2 Incubator emphasizes hands-on involvement, supporting founders from ideation through Series A. It also offers extensive technical guidance, customer discovery assistance, and access to a network of AI experts. Founders from diverse backgrounds—engineers, scientists, product leaders—are encouraged to apply, with the incubator prioritizing teams that are passionate about solving real-world problems through AI. The incubator is led by a team of seasoned AI professionals, including Oren Etzioni and Jacob Colker, who work closely with startups to ensure their success in building innovative products and scaling their businesses. With deep ties to the AI2 research institute, AI2 Incubator helps startups leverage cutting-edge research to build impactful, scalable products. This unique combination of early capital, expert mentorship, and technical support has made AI2 Incubator a key player in fostering the next generation of AI-first companies.

AlleyCorp, founded by New York internet entrepreneur Kevin Ryan, is both a startup studio and venture capital fund. The firm is known for launching and investing in transformative companies primarily in New York City. AlleyCorp is responsible for building some of New York’s most iconic tech companies, including MongoDB, Business Insider, Gilt Groupe, Zola, and Nomad Health. The firm operates across several dedicated verticals: Diversified Technology, Healthcare, Robotics, and Economic Infrastructure. They are highly active in the early stages of investment, focusing mainly on pre-seed and seed rounds, often being the first check in. They also make select Series A investments. AlleyCorp takes a hands-on approach by originating ideas, hiring teams, providing initial funding, and maintaining leadership throughout the company's lifecycle. Their portfolio includes notable startups such as Affect Therapeutics, RippleMatch, and Properly, covering diverse industries from digital health to real estate technology. The firm’s strategy is characterized by deep involvement and long-term partnership with its portfolio companies, supporting them from inception through to potential IPOs. AlleyCorp’s team is composed of seasoned startup operators and investors, including General Partners like Jay Hass and Marshall Porter, and specialists like Brenton Fargnoli, MD, in healthcare investments. This robust team ensures that the companies they back have the support and resources needed to thrive.

Alliance of Angels, founded in 1997, is the largest and most active angel group in the Pacific Northwest. Based in Seattle, AoA comprises over 180 accredited investors who collectively invest more than $10 million annually into around 20 startups. The group primarily focuses on high-growth companies in technology, hardware, consumer products, and life sciences sectors. AoA has generated over $1 billion in returns from exits, with notable successes including DocuSign, Elemental Technologies, and BuddyTV. AoA's investment process begins with an introductory meeting, followed by a screening committee review, a member meeting presentation, and a due diligence phase. They typically invest between $500,000 to $2.5 million in seed and early-stage rounds, often co-investing with other angel groups and venture funds. The Alliance of Angels Innovation Fund, an annual fund, provides additional capital with quick decision-making processes. AoA's portfolio features diverse investments such as Proton Intelligence, Anuncia Medical, Phase Genomics, and Olis Robotics. They support startups from Washington, Oregon, Idaho, Montana, British Columbia, and Alaska, though they also consider opportunities across the US and Canada.

Allos Ventures, based in Indianapolis, Indiana, focuses on investing in early-stage B2B software and tech-enabled service companies, primarily within the Midwest. The firm, co-founded by Don Aquilano, John McIlwraith, and David Kerr, emphasizes a hands-on approach, leveraging over fifty years of combined experience to support the growth of high-tech companies​. Allos Ventures recently closed its fourth fund, Allos IV, aiming to invest $75 million in promising startups. This fund continues the firm's strategy of backing high-growth software companies in the Midwest, building on successful investments in companies like Lessonly, Assurex Health, and Authenticx​. The firm prefers to lead or co-lead investment rounds, providing initial checks ranging from $500K to $10M. They focus on Series A and B investments in companies that have an existing product or service generating revenue but are still a few years away from profitability. Notable portfolio companies include 120Water, Encamp, and Aware, among others. Allos Ventures is known for its commitment to the Midwest entrepreneurial ecosystem, supporting founders with deep industry expertise and helping them scale rapidly by attracting top talent from across the country.

Harvard Innovation Labs (i-lab) stands out as a leading incubator and accelerator for startups, with a significant portfolio of impactful ventures. Notable investments include Manifold Bio, which raised $40 million to advance its biologics discovery platform, and Akouos, a gene therapy company acquired by Eli Lilly for over $600 million. Focusing on diverse industries such as biotechnology, edtech, and sustainability, i-lab supports ventures like BioDevek in medical devices and Earthbond in renewable energy. Geographically, their impact spans globally, benefiting startups from the U.S. to Vietnam. i-lab’s strategy centers on providing comprehensive support through programs like Launch Lab X GEO, offering resources for early-stage ventures to grow sustainably. The fund emphasizes collaboration, preferring to lead rounds and actively engaging in the growth journey of their startups. They typically offer pre-seed funding ranging from $10,000 to $100,000, focusing on high-potential, high-impact ventures. Key figures at i-lab include Jodi Goldstein, the Executive Director, who brings extensive experience in entrepreneurship and innovation. The team is based in Cambridge, MA, leveraging Harvard’s vast network and resources. For startups, approaching i-lab requires demonstrating innovative solutions with clear market potential. The fund values ventures that address significant challenges and show strong potential for scalability and impact.

Almi Invest is Sweden's most active early-stage venture capital firm, focusing on investing in startups across various sectors, including technology, life sciences, industry, and cleantech. As part of the state-owned Almi Group, Almi Invest operates through eight regional funds and a specialized national GreenTech fund, which targets climate-smart investments that contribute to CO2 reduction. The firm has recently raised €140 million (approximately SEK 1.6 billion) for its third investment fund, which will be deployed from 2024 to 2029. This fund aims to support around 300 startups, continuing Almi's tradition of nurturing early-stage companies across Sweden. Over its history, Almi Invest has backed nearly a thousand companies, achieving over 600 successful exits. This track record has established the firm as a cornerstone of Sweden's startup ecosystem, with many portfolio companies eventually being acquired by global giants like Google, Microsoft, and Apple. Almi Invest's regional presence is critical to its strategy, ensuring that startups throughout Sweden have access to the capital and support they need to grow. The firm’s focus on sustainability and innovation aligns with Sweden’s broader goals of fostering a vibrant, future-oriented economy.

Aloft VC, led by Crystal McKellar, invests in early-stage technology companies addressing critical challenges in healthcare, national security, and fintech. Some standout portfolio companies include Vannevar Labs (national security tech), Angle Health (AI-enabled healthcare), and Cooler Heads (FDA-approved cancer care devices). The firm has a sharp focus on national security and defense tech, leveraging Crystal’s deep connections from her work with Peter Thiel and Palantir. Aloft typically participates in early-stage rounds and often leads investments, as seen with Cooler Heads. The average check size is flexible depending on the round, but the firm actively builds its pipeline through founder referrals and strategic partnerships in Silicon Valley’s defense and healthcare circles. Startups that align with Aloft’s mission to solve high-impact, systemic problems in its focus sectors are encouraged to approach them with well-developed technology solutions and clear market differentiation. McKellar’s experience spans law and venture capital, with notable prior investments in companies like Palantir and Siren Care. Based in San Francisco, Aloft VC maintains a tight-knit network of experts in tech and defense, offering founders more than just capital—strategic insights and meaningful introductions to fuel growth.

Alon MedTech Ventures is a leading venture capital firm based in Israel, focusing on the incubation and growth of early-stage medical device companies. Founded and chaired by Dr. Shimon Eckhouse, a well-known inventor and entrepreneur in the medical technology sector, Alon MedTech plays a critical role in advancing innovative healthcare solutions that aim to improve global well-being. The firm operates as part of Israel’s Innovation Authority incubator system, providing startups with not only financial backing but also strategic guidance, access to state-of-the-art facilities, and industry expertise. Alon MedTech's investment strategy emphasizes novel technologies that have the potential to revolutionize medical practices and patient outcomes. Alon MedTech’s portfolio includes a variety of groundbreaking companies, such as Hallura, which is developing next-generation hyaluronic acid dermal fillers using a unique crosslinking technology, and SofWave, which offers non-invasive skin tightening solutions using ultrasound technology. The firm’s approach is highly hands-on, working closely with entrepreneurs from the ideation stage through to commercialization, ensuring that these companies can scale successfully and impact the healthcare industry globally. The firm’s commitment to innovation and deep engagement with portfolio companies has positioned it as a key player in the medical device sector, particularly within Israel’s vibrant tech ecosystem.

Alpha Edison, based in Los Angeles, is a venture capital firm that partners with early-stage entrepreneurs to build category-defining companies. Founded in 2016 by Michael Parekh, Alpha Edison focuses on investing in technology-driven sectors such as software, data and behavioral science, artificial intelligence, and machine learning. Notable investments by Alpha Edison include Comparably, Rize, Brainbase, and Greenfly. These investments highlight their commitment to fostering innovative solutions across various industries​​. The firm's investment strategy centers on identifying latent demand and supporting founders in unlocking new markets, with an emphasis on leveraging technology to drive growth and transformation. Alpha Edison typically engages at the Series A and B stages, providing substantial operational support and strategic guidance to help scale businesses effectively. Their approach is characterized by a deep understanding of market behaviors and a focus on data-driven insights to ensure sustainable growth and market impact​. The team at Alpha Edison includes experienced partners like Britt Danneman, Robey Miller, and Steve Horowitz, who bring diverse expertise in investment and entrepreneurial support. This cognitively diverse team is dedicated to helping founders navigate the complexities of scaling their businesses and achieving long-term success.

AI Capital is a venture capital firm based in Denver, with operations spanning North America, Europe, and Asia. It focuses on early-stage investments in AI-driven companies, particularly in enterprise software and data platforms. The firm’s primary industry targets are healthcare, life sciences, and core industries like energy and manufacturing, where AI can optimize supply chains and critical services. Additionally, AI Capital invests heavily in cybersecurity, recognizing its importance across these sectors. The firm typically invests in Seed to Series B rounds, bringing a strong combination of technical expertise and deep investment experience. Recent notable portfolio companies include Link3D, Syndesis Health, and Luminoso. AI Capital emphasizes transformative AI applications, from VR therapy to advanced genomic solutions. They aim to support companies with high growth potential and significant societal impact. The firm is led by experienced partners like Neville Teagarden and Andrew Maus, with a team composed of AI specialists and seasoned investors. They value companies solving real-world problems through breakthrough AI technologies. AI Capital often leads rounds and is known for being highly involved with its portfolio companies, offering both strategic and operational support. Founders are encouraged to approach them through established networks or referrals, particularly those innovating in AI's frontier sectors.

Alpha Wave Global, originally founded as Falcon Edge Capital in 2012, is a global investment firm based in New York. The firm focuses on growth and expansion-stage investments across a wide range of sectors, including information technology, fintech, AI, and life sciences. With a portfolio of over 200 investments, Alpha Wave has been involved in backing high-profile companies such as SpaceX, Lenskart, and Ola Electric. Alpha Wave operates through multiple funds, including Alpha Wave Ventures and Alpha Wave Incubation, targeting venture and growth-stage companies worldwide. The firm has offices across major global hubs, including New York, Miami, London, Abu Dhabi, and Tel Aviv, and manages over $10 billion in assets. Its approach emphasizes long-term partnerships with founders, providing both capital and strategic guidance to help companies scale.

Alter Equity, based in Paris, is a pioneering impact investment firm founded by Fanny Picard. The firm focuses on companies that provide solutions to environmental and social challenges, adhering to an ESG-driven model that prioritizes sustainable growth. Launched in 2013, Alter Equity’s investment strategy revolves around supporting European companies with a strong focus on sectors such as renewable energy, circular economy, green chemistry, education, and well-being. They typically invest between €3 million and €10 million in companies with annual revenues above €800,000 that demonstrate strong growth potential. The firm’s portfolio includes companies like Teale, a mental health platform, Beem, which provides photovoltaic kits, and Neobrain, a human resources tech company focusing on employment management and skills development. Alter Equity is particularly committed to gender diversity, with 33% of its portfolio companies led by women, one of the highest rates in French private equity. Alter Equity stands out for its measurable impact. Its portfolio companies have collectively saved 6.8 million tons of CO2 since the firm's inception, aligning with its mission to contribute to both social and environmental sustainability.

Althelia Climate Fund, managed by Mirova Natural Capital, is a pioneering impact investment fund focused on natural capital. Its core strategy revolves around mitigating climate change, protecting biodiversity, and promoting sustainable land use, particularly in Africa and Latin America, with a secondary focus on Asia. The fund has been highly active since its launch in 2013, notably investing in projects that generate environmental credits, such as forest carbon credits, which are sold to voluntary offset markets. Althelia's investment philosophy emphasizes "blended value," combining strong financial returns with social and environmental outcomes. The fund's investments target agroforestry, ecosystem conservation, and carbon emissions reduction. Althelia's portfolio has been designed to tackle deforestation frontiers, collaborating with public-private partnerships and leveraging institutional support from entities like USAID. The average investment size typically ranges from €5 million to €8 million, often taking a lead in project development. Key personnel, such as Edit Kiss and the broader Mirova team, are based in Europe, with extensive experience in environmental markets and sustainable finance. They prefer projects aligned with measurable ecological and social impacts. Startups seeking funding should demonstrate both economic resilience and a clear environmental mission, with a preference for early engagement during project development.

Altimeter Capital is a prominent investment firm with a focus on technology-driven companies across both public and private markets. Founded by Brad Gerstner in 2008, the firm is headquartered in Boston, Massachusetts, with a significant presence in Menlo Park, California. Altimeter is known for its substantial investments in companies such as Snowflake, Uber, and Grab. The firm employs a growth-oriented investment strategy, often taking significant positions in companies with high potential for long-term growth. Altimeter manages a mix of hedge fund assets and private growth equity funds, with its public equity fund prominently featuring large holdings in technology giants like Meta, Amazon, and Nvidia. Altimeter Capital has made a total of 103 investments, including high-profile exits such as Snowflake, which provided a substantial return when it went public. Other notable investments include 23andMe, AppDynamics, and ByteDance​. The firm's investment activities are characterized by a strong emphasis on technology sectors, with significant allocations to cloud computing, fintech, and enterprise softwar. The firm is led by Brad Gerstner, who is well-regarded for his strategic insights and investment acumen. Altimeter's approach is to support visionary entrepreneurs who are transforming industries through innovation. This focus on transformative potential has made Altimeter a key player in the tech investment landscape, often participating in late-stage funding rounds and public offerings​. For startups and companies looking to engage with Altimeter, demonstrating robust growth potential and technological innovation is crucial. The firm's track record and strategic focus on impactful tech investments make it a significant force in the venture capital and hedge fund arenas​.

Altitude Ventures, commonly known as AV, is a venture capital firm focused on accelerating growth in healthcare services and digital health companies. Based in Nashville, Tennessee, and Houston, Texas, Altitude Ventures leverages its extensive industry experience and a deep network of healthcare professionals to provide more than just capital to its portfolio companies. The firm is particularly known for its hands-on approach, where they actively engage with partners to recruit talent, support operations, and provide strategic guidance. AV's investment strategy is centered around making early-stage investments, typically ranging from $2 million to $4 million, with a strong emphasis on maintaining significant stakes in its portfolio companies. The firm reserves a majority of its investable capital for follow-on investments, ensuring that companies have the necessary resources to scale through various growth stages. Founded on the legacy of the late Clayton McWhorter, a healthcare industry pioneer, Altitude Ventures continues to be guided by the principles of integrity and operational excellence that McWhorter championed throughout his career. The firm’s portfolio includes companies like Spiras Health, Mindoula, and Itiliti Health, all of which are innovators in the healthcare and digital health sectors. With over 50 years of collective experience in healthcare and investment, Altitude Ventures has built a robust network of payors, health systems, and providers, making it a key player in the healthcare venture capital space​.

Altos Ventures, founded in 1996 and based in Menlo Park, California, is a prominent venture capital firm managing over $10 billion in assets. Known for its early-stage investments, Altos Ventures focuses on consumer and enterprise technology companies. Some of their most notable investments include Coupang, Woowa Brothers, Roblox, and Toss, with Coupang achieving a valuation exceeding $100 billion at its IPO​. Altos Ventures typically makes initial investments ranging from $1 to $5 million, aiming to support the full lifecycle of their portfolio companies. They are known for their hands-on approach, providing significant operational support and partnering closely with management teams to build strong, scalable businesses​. Their investment strategy emphasizes strong operating fundamentals and attractive unit economics, targeting emerging opportunities in both the consumer and enterprise sectors. The firm has a significant presence in Asia, particularly in Korea and Japan, where they have successfully backed several unicorns​. Key figures at Altos Ventures include co-founders Han Kim and Ho Nam, who bring extensive experience and a deep understanding of the startup ecosystem. Startups seeking investment from Altos should demonstrate robust business models and the potential for long-term growth.

Venture Kick, based in Switzerland, has been a crucial player in the early-stage startup ecosystem since 2007. This philanthropic initiative provides pre-seed funding of up to CHF 150,000 to promising startups, helping them transition from innovative ideas to market-ready products. Venture Kick's portfolio includes over 1,000 startups, which collectively have attracted more than CHF 8 billion in investments and created over 13,300 jobs. Some notable successes from Venture Kick include Climeworks, a leader in direct air capture technology, which raised CHF 600 million to scale its operations, and YASAI, a vertical farming company that secured significant investment to accelerate its growth. In 2023 alone, Venture Kick supported 118 projects with CHF 6.23 million, focusing on high-tech sectors like ICT, life sciences, cleantech, and advanced manufacturing. Venture Kick aims to continue its impactful work, with goals to support 3,000 high-tech companies and create 100,000 jobs by 2033. The initiative's structured, three-stage funding process and focus on early-stage startups fill a critical gap in the funding landscape, supporting ventures that may not yet attract public or private investment​.

Amadeus Capital Partners, founded by Anne Glover and Hermann Hauser in 1997, is a renowned global technology investor. The firm has backed over 190 companies and raised more than $1 billion in investment capital. They focus on AI and machine learning, online consumer services, cyber security, digital health and medical technology, digital media, enterprise SaaS, fintech, regtech, and insurtech. Notable investments in their portfolio include Graphcore, FiveAI, Congenica, Sprout.ai, and Seldon. Amadeus follows a multi-faceted investment strategy: providing seed, start-up, and scale-up capital for early-stage companies in the UK, primary and secondary investments in high-growth tech companies in Europe, and growth capital for tech-enabled consumer and business services in emerging markets. They typically invest in companies with exceptional IP that have the potential to become global champions. With offices in Cambridge, London, San Francisco, and Cape Town, Amadeus Capital Partners supports scaling businesses with technical insight, operational experience, and access to a global network, including mentorship and non-executive directors. Their recent £110 million Amadeus V Technology Fund highlights their commitment to deep tech investment, with significant backing from British Patient Capital. Amadeus prefers to invest in companies that demonstrate a strong team, competitive edge, and the potential for global market impact. Founders should approach them with a well-articulated market opportunity and technological innovation to capture their interest.

AME Cloud Ventures, founded by Yahoo! co-founder Jerry Yang, is a leading venture capital firm investing in data-driven companies. Notable investments include Zoom, Wish, Zymergen, Planet, and Freenome. The firm focuses on tech-heavy industries, particularly those involved in data infrastructure, applications, mobile, and sensors. AME Cloud Ventures operates globally with a strong emphasis on U.S. and China-based companies. Their strategy is to back visionary entrepreneurs, providing not just capital but also strategic guidance and a vast network of mentors and international partners. Their typical check size ranges from $2 million to $10 million for early-stage investments, with larger sums for later stages. They are known for their active role in portfolio companies, offering operational support and leveraging industry connections to foster growth and innovation. Key team members include Jerry Yang and Jeff Chung, who focus on empowering big thinkers and frontier technologies. The team, based in Palo Alto, California, includes experts in various fields such as manufacturing, biology, and intelligent robotics. Startups looking to engage with AME Cloud Ventures should seek introductions through their network and highlight how their innovative use of data aligns with AME's strategic vision. This, along with a strong business model and growth potential, increases the likelihood of securing investment from this influential fund

Amino Capital, based in Palo Alto, is a global venture capital firm focused on seed to growth-stage investments, with a particular emphasis on data-driven startups and technologies that create network effects. Founded by Larry Li, the firm manages over $1 billion in assets and has invested in a diverse array of sectors including Consumer Tech, PLG SaaS, Frontier Tech, AI, and Web3. Amino Capital's portfolio boasts over 200 companies, with notable investments in Chime, Webflow, Rippling, Grail, Weee!, Replit, and Turing. They have a track record of successful exits, with 25 exits and 17 companies achieving unicorn status. Their investment strategy centers on leveraging data moats to create sustainable competitive advantages for their portfolio companies. The firm is geographically focused primarily on the US, China, and parts of Europe, reflecting a broad international investment strategy. Their team, led by Larry Li and other experienced partners, provides significant value-add through strategic guidance, operational support, and extensive industry connections. For startups looking to engage with Amino Capital, the key is to demonstrate how their technology leverages data to create substantial network effects and competitive advantages. The firm looks for resilient and adaptable teams that can thrive in rapidly evolving tech environments. Larry Li, a former entrepreneur himself, emphasizes the importance of energetic and reflective teams in driving innovation.

Amino Collective is a Berlin-based venture capital firm with a primary focus on health and biotechnology. They specialize in backing early-stage ventures, especially those in the pre-seed to Series A stages, with investments ranging from $250,000 to $5 million. The firm is deeply committed to transforming healthcare through strategic partnerships with entrepreneurs and scientists who are pushing the boundaries of bio and health tech. Amino Collective's mission is to bring life-changing ideas to fruition, supporting founders who are "free and radical," unafraid to challenge established norms. The fund primarily targets European-based startups with the ambition to scale globally. Notable investments include Lindus Health, Molecule, and Nostos Genomics. Led by co-founders like Manuel Grossmann, Amino Collective is not just about providing capital but also about offering mentorship and fostering innovation in sectors like digital health, medical devices, and biotech. Their approach is focused on long-term impact, aiming to shape a better future by leveraging the latest advancements in science and technology.

Amplify Partners, founded in 2012 and headquartered in Menlo Park, California, is a venture capital firm specializing in early-stage investments. The firm focuses on areas such as information technology, machine intelligence, infrastructure, and developer tools, supporting technical founders building the next generation of applications and platforms. Amplify Partners has a notable portfolio, including investments in companies like Datadog, a leader in cloud monitoring and security; Fastly, a real-time content delivery network; and Scribe, which automates the documentation of processes. They have also invested in emerging startups such as Meroxa, a data streaming platform, and Metaphor, a search and discovery tool for data scientists. The firm has made over 258 investments, demonstrating a strong track record of identifying and nurturing innovative tech companies. Amplify Partners is also known for its significant exits, including Intellimize and Minerva Labs. Their investment approach combines providing capital with deep operational support, leveraging their extensive industry experience to help portfolio companies scale effectively. Amplify Partners recently expanded their Amplify Select Fund to $200 million, emphasizing their commitment to supporting their portfolio companies through various growth stages and into the public markets. This expansion allows them to double down on their most promising investments, ensuring sustained growth and success for their portfolio companies.

Amplifyher Ventures, founded in 2018 and based in New York City, is a venture capital firm dedicated to investing in early-stage startups led by exceptional women. The fund's mission is to bridge the gender gap in leadership roles by supporting female founders and fostering diversity within the entrepreneurial ecosystem. Key investments include companies like Copper Cow Coffee, Expressable, and Summersalt, showcasing their focus on consumer products, e-commerce, and health tech. The firm emphasizes industries such as commerce, care, and connectivity, seeking out businesses that leverage community-driven marketing for exponential growth. Amplifyher Ventures typically invests in pre-seed, seed, and Series A rounds, with an average investment size of $2 million. Their strategic approach involves not just financial support but also leveraging their extensive network and marketing expertise to help startups scale efficiently without relying heavily on traditional advertising platforms like Facebook and Google. The team is led by Tricia Black, a seasoned venture capitalist with a background in high-growth business roles, and Meghan Cross, a former startup marketer and experienced VC. Both are based in New York and bring a wealth of experience in identifying and nurturing high-potential ventures. Amplifyher Ventures is known for its hands-on approach, actively engaging with portfolio companies to provide mentorship and strategic advice, thereby maximizing their chances of success​.